Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells. Potenza A, Balestrieri C, Spiga M, Albarello L, et al. Gut 2023 Jun 30:gutjnl-2022-328042. doi: 10.1136/gutjnl-2022-328042.

Read + Share

Amedeo Smart

Independent Medical Education

Potenza A, Balestrieri C, Spiga M, Albarello L, et al. Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells. Gut 2023 Jun 30:gutjnl-2022-328042. doi: 10.1136/gutjnl-2022-328042.
PMID: 37399271